<DOC>
	<DOCNO>NCT02515331</DOCNO>
	<brief_summary>The purpose present study determine whether LHW090 display clinical safety efficacy profile support development patient resistant hypertension .</brief_summary>
	<brief_title>Safety Efficacy Study LHW090 Resistant Hypertension Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male female patient , age 40 85 year inclusive . • Patients uncontrolled hypertension ( define mean daytime systolic BP ≥ 135 mmHg ABPM screening ) despite treatment stable ( least 1 month ) regimen include optimal dose ARB plus diuretic plus least one additional class antihypertensive medication . For purpose trial , optimal dos antihypertensive medication define : high dose list clinical practice guideline American Society Hypertension International Society Hypertension high allowable prescribed dose per manufacturer 's label high dose tolerate individual patient high dose appropriate individual patient judgment Investigator Subjects must weigh least 45 kg participate study must body mass index ( BMI ) within range 1838 kg/m^2 . Patients estimate GFR &lt; 60 ml/min/1.73m^2 . Use angiotensin convert enzyme inhibitor ( ACEinhibitors ) . Note : Patients discontinue ACEinhibitor substitute angiotensin receptor blocker may eligible rescreened provided antihypertensive regimen stable least 1 month . Any substitution change patient 's antihypertensive regimen do guidance patient 's treating physician . Severe hypertension define systolic blood pressure ≥180 mmHg diastolic blood pressure ≥110 mmHg screening . A history secondary hypertension etiology include limited unilateral bilateral renal artery stenosis , polycystic kidney disease , coarctation aorta , primary hyperaldosteronism , Cushing 's disease , pheochromocytoma , druginduced hypertension . Known current significant leave ventricular outflow obstruction , obstructive hypertrophic cardiomyopathy significant severe valvular disease prior current echocardiogram ) . A history know moderate malignant retinopathy define moderate ( retinal sign hemorrhage ) , microaneurysms , cottonwool spot , hard exudate , combination thereof ) malignant ( sign moderate retinopathy plus swelling optic disk ) . Patients stable ophthalmologic history past 6 month eligible . To facilitate ABPM assessment , upper arm circumference great 42 cm . History within previous 6 month myocardial infarction , coronary artery bypass graft ( CABG ) , percutaneous coronary intervention ( PCI ) , hypertensive encephalopathy , stroke , transient ischemic attack ( TIA ) . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test . • Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>resistant hypertension</keyword>
</DOC>